• Lead business development efforts for newly acquired B-MoGen Biotechnologies in the genome engineering space. Exceeded revenue targets (FY21 – 131%, FY22 – 154%).• Oversee OEM and CRO business development efforts. • Manage Serum/Cell Culture sales team (North America).

• Managed Central US field sales team for both instrumentation and core reagents.• Negotiated multimillion-dollar custom ELISA development agreement with strategic biopharma account.• Exceeded regional growth targets in FY19 and FY20.• Every individual on sales team exceeded revenue targets in FY19 and FY20.

• Manage day-to-day operations of Biotech Division OEM accounts in North America• Responsible for key OEM account growth and business development efforts.• Negotiated and managed strategic license, supply, and royalty agreements with corporate partners.• Managed key North American distributor relationships on a commercial level.

• Responsible for the placement of diagnostic autoimmune and infectious disease automated instrumentation. Instruments include: BioPlex 2200 (IA Multiplex), PhD LX (IFA/EIA), and Evolis (EIA).• Performance objectives included: Achievement of territory revenue and instrument placement goals.• Required to give both technical and financial presentations to customers at both the lab and executive management levels.• Responsible for the negotiation of multi-year contracts for both instrumentation and related reagents.• Key focus was given to working with local Account Managers in the various Midwestern states to identify and qualify prospective customers.

• Responsible for growing and maintaining diagnostic reagent and QC business.• Rookie of The Year Award - 2006• Rockies Region Account Manager of The Year - 2007, 2008, 2009• Clinical Microbiology Division Account Manager of The Year - 2007, 2011• Clinical Systems Division Account Manager of The Year - 2008• $3 Million Dollar Club - Awarded 2011 ($3M Territory Growth in 5 Years or Less)• Leadership Award - 2006, 2007, 2008 (Top Ten Account Managers Nationally)• Negotiated the Mayo Foundation Master Agreement.• Negotiated the NPPC/Premier IDN Agreement (Avera Health / Regional Health) for Immunohematology Division reagents in South Dakota with a contracted compliance tag of 95%.

• Key Accounts Manager for the $16M Northeast Territory spanning 7 states / 3 Canadian provinces.• Increased territory sales by over 40% in first year.• Achieved territory growth of over 21% in FY2005 - #1 on sales team.

• Conducted quality control tests on antibody products including protein concentration determination, endotoxin level, SDS PAGE gel electrophoresis, Western Blot, and ELISA.• Assisted management in employee training.• Assisted in writing and modifying laboratory protocols and SOP's.